These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13660839)

  • 21. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
    SZABO IK
    Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
    [No Abstract]   [Full Text] [Related]  

  • 22. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaphylactic shock in zymosan pre-treated guinea-pigs. (A study on the possible role of properdin)].
    WILHELM RE; SALVAGGIO J; KRUPP I
    Int Arch Allergy Appl Immunol; 1961; 18():318-29. PubMed ID: 13831364
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
    ZSEBOK Z; WACHTL I; SZY S; SELLEI G
    Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of properdin in murine zymosan-induced arthritis.
    Dimitrova P; Ivanovska N; Schwaeble W; Gyurkovska V; Stover C
    Mol Immunol; 2010 Apr; 47(7-8):1458-66. PubMed ID: 20226532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
    MAZZEI D; TASCHINI P
    Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the problem of the method of determination of properdin in human serum by the zymosan method].
    MASHKOV AV; MIKHAILOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G
    Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of the bactericidal activity of the properdin system by zymosan and other properdin binding agents.
    WARDLAW AC; PILLEMER L
    J Immunol; 1959 Apr; 82(4):313-8. PubMed ID: 13641665
    [No Abstract]   [Full Text] [Related]  

  • 31. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ULTRACENTRIFUGE STUDIES ON PROPERDIN SERA OF ZYMOSAN-VACCINATED CATTLE, RABBITS, GUINEA PIGS, RATS AND MICE AND ON BOVINE PROPERDIN SERUM FRACTIONS].
    ZIMMERMANN G; KRUEGER K
    Acta Biol Med Ger; 1963; 11():902-17. PubMed ID: 14121884
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
    Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G
    Acta Biol Med Ger; 1962; 9():412-27. PubMed ID: 14003718
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex.
    LEON MA
    J Immunol; 1958 Jul; 81(1):23-8. PubMed ID: 13563875
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE INTERRELATIONSHIP BETWEEN THE BLOOD PROPERDIN LEVEL, ANTISTREPTOLYSIN TITER, LEUKOCYTE COUNT AND ERYTHROCYTE SEDIMENTATION RATE IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS PATIENTS].
    MATJEW M; TOSZKOW A
    Reumatologia; 1963; 1():25-7. PubMed ID: 14184247
    [No Abstract]   [Full Text] [Related]  

  • 37. An alternative mechanism for the properdin system.
    NELSON RA
    J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The usefulness of various zymosan preparations in determination of properdin].
    von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
    Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Properdin in the course of chronic inflammatory rheumatism; comparative study by hemolysis inhibition & neutralization of bacteriophage T2r+].
    EYQUEM A; FRANCQ JC; GUYOT-JEANNIN N; JACQUELINE F
    Ann Inst Pasteur (Paris); 1958 Dec; 95(6):748-53. PubMed ID: 13617714
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the mechanism of properdin--zymosan reaction. The role of polysaccharide structure in combination with properdin.
    CSEH G; SZABO I
    Acta Microbiol Acad Sci Hung; 1961; 8():181-7. PubMed ID: 13718704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.